Related references
Note: Only part of the references are listed.Loss of PTEN Binding Adapter Protein NHERF1 from Plasma Membrane in Glioblastoma Contributes to PTEN Inactivation
Jennifer R. Molina et al.
CANCER RESEARCH (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Meng Qiao et al.
MOLECULAR CELL (2010)
NHERF1/EBP50 Is a New Marker in Colorectal Cancer
Yuho Hayashi et al.
NEOPLASIA (2010)
Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation
Jennifer R. Molina et al.
NEOPLASIA (2010)
Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis
J. Liu et al.
ONCOGENE (2009)
A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN
Meghdad Rahdar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Roles of NHERF1/EBP50 in cancer
Maria-Magdalena Georgescu et al.
CURRENT MOLECULAR MEDICINE (2008)
PI3K/Akt: getting it right matters
T. F. Franke
ONCOGENE (2008)
PHUPPing the switch on Akt and protein kinase C signaling
John Brognard et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells
Yong Pan et al.
BREAST CANCER RESEARCH (2008)
Cortical stabilization of β-catenin contributes to NHERF1/EBP50 tumor suppressor function
E. L. Kreimann et al.
ONCOGENE (2007)
Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer
J. Song et al.
HISTOPATHOLOGY (2007)
The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells
Rosa A. Cardone et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands
Fabiana C. Morales et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms
John Brognard et al.
MOLECULAR CELL (2007)
NCBI GEO: mining tens of millions of expression profiles - database and tools update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2007)
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
LX Sun et al.
CANCER CELL (2006)
PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling
Y Takahashi et al.
EMBO JOURNAL (2006)
PHLPP: A phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth
TY Gao et al.
MOLECULAR CELL (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif
SM Walker et al.
BIOCHEMICAL JOURNAL (2004)
The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface
CS Lazar et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
EBP50, a β-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma
T Shibata et al.
HEPATOLOGY (2003)
N-terminal PDZ domain is required for NHERF dimerization
S Shenolikar et al.
FEBS LETTERS (2001)
Platelet-derived growth factor receptor association with Na+/H+ exchanger regulatory factor potentiates receptor activity
S Maudsley et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Evidence for ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) self-association through PDZ-PDZ interactions
L Fouassier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
